Anterix Inc. (ATEX) earnings date, results and what the price requires
Nasdaq · SEC CIK 0001304492 · SEC filings checked Oct 17, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 11, 2026 | $2.0M | $240,000 | $0.01 | Filing |
| Mar 31, 2026 | Jun 10, 2026 | $2.0M | $-72.0M | $0.97 | Filing |
| Dec 31, 2025 | Feb 11, 2026 | $1.6M | $-6.6M | $-0.35 | Filing |
| Sep 30, 2025 | Nov 12, 2025 | $1.6M | $53.5M | $2.86 | Filing |
| Jun 30, 2025 | Aug 12, 2025 | $1.4M | $25.2M | $1.35 | Filing |
| Mar 31, 2025 | Jun 24, 2025 | $1.4M | $20.6M | $0.51 | Filing |
| Dec 31, 2024 | Feb 11, 2025 | $1.6M | $7.7M | $0.41 | Filing |
| Sep 30, 2024 | Nov 13, 2024 | $1.6M | $-12.8M | $-0.69 | Filing |
What would Anterix Inc. have to report for its valuation to change?
At $80.48, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 14.5% a year, to $6.88. On that path the next quarter needs diluted EPS near $3.28, against $2.86 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | 14.5% | 14.5% |
| EPS needed in final year | $6.88 | $6.88 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. ATEX goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.